Cannabinoid and Glutamate Systems May Jointly Disrupt Brain Oscillations in Psychosis
CB1 receptor agonists and NMDA receptor antagonists both reduce GABAergic signaling on interneurons, disrupting the theta and gamma brain oscillations that are critical for cognition - a potential shared mechanism underlying psychosis.
Quick Facts
What This Study Found
CB1Rs and NMDARs have direct and indirect interactions in brain regions implicated in schizophrenia (hippocampus, frontal cortex, cerebellum). Both systems converge on GABA interneurons: CB1R agonists and NMDAR antagonists each reduce GABAergic neurotransmission, leading to unsynchronized pyramidal neuron activity and disrupted neural oscillations involved in information processing.
Key Numbers
Theta oscillations (4-7 Hz) and gamma oscillations (30-80 Hz) are the key frequencies discussed. Three brain regions examined: hippocampus, frontal cortex, and cerebellum.
How They Did This
Review synthesizing literature on cannabinoid-glutamate interactions in the context of neural oscillations and schizophrenia, aiming to bridge the "cannabis model" and "ketamine model" of psychosis.
Why This Research Matters
Schizophrenia research has developed separate cannabinoid and glutamate models of the disorder. This review argues these are not competing explanations but complementary mechanisms that converge on disrupted brain oscillations, potentially explaining why cannabis use increases psychosis risk.
The Bigger Picture
Unifying the cannabinoid and glutamate models of schizophrenia could lead to more comprehensive treatment approaches that target the shared downstream effects rather than individual receptor systems.
What This Study Doesn't Tell Us
Largely theoretical synthesis. Much evidence comes from acute drug administration studies rather than chronic exposure. The relationship between oscillatory disruptions and clinical symptoms is complex and not fully understood.
Questions This Raises
- ?Could combined CB1R and NMDAR modulation be more effective than targeting either system alone?
- ?Do chronic cannabis users show the predicted oscillatory disruptions?
- ?Could oscillatory measures serve as biomarkers for cannabis-related psychosis risk?
Trust & Context
- Key Stat:
- CB1R agonists and NMDAR antagonists both reduce GABA interneuron signaling, converging on the same disrupted brain oscillation patterns seen in schizophrenia.
- Evidence Grade:
- Moderate - well-reasoned theoretical synthesis of existing evidence, but largely speculative regarding combined mechanisms.
- Study Age:
- Published in 2018.
- Original Title:
- Cannabinoid-glutamate interactions and neural oscillations: implications for psychosis.
- Published In:
- The European journal of neuroscience, 48(8), 2890-2902 (2018)
- Authors:
- Sherif, Mohamed A, Cortes-Briones, Jose A(5), Ranganathan, Mohini(13), Skosnik, Patrick D
- Database ID:
- RTHC-01836
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
How do cannabis and glutamate systems relate in the brain?
CB1 cannabinoid receptors and NMDA glutamate receptors interact directly and indirectly in key brain regions. Both systems affect GABA interneurons, and disrupting either one can produce similar effects on brain oscillations linked to psychosis.
What are brain oscillations and why do they matter for psychosis?
Brain oscillations are rhythmic patterns of neural activity (like theta at 4-7 Hz and gamma at 30-80 Hz) that coordinate information processing. Disrupted oscillations are consistently found in schizophrenia and may underlie cognitive symptoms.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
Cite This Study
https://rethinkthc.com/research/RTHC-01836APA
Sherif, Mohamed A; Cortes-Briones, Jose A; Ranganathan, Mohini; Skosnik, Patrick D. (2018). Cannabinoid-glutamate interactions and neural oscillations: implications for psychosis.. The European journal of neuroscience, 48(8), 2890-2902. https://doi.org/10.1111/ejn.13800
MLA
Sherif, Mohamed A, et al. "Cannabinoid-glutamate interactions and neural oscillations: implications for psychosis.." The European journal of neuroscience, 2018. https://doi.org/10.1111/ejn.13800
RethinkTHC
RethinkTHC Research Database. "Cannabinoid-glutamate interactions and neural oscillations: ..." RTHC-01836. Retrieved from https://rethinkthc.com/research/sherif-2018-cannabinoidglutamate-interactions-and-neural
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.